These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20838083)

  • 1. Methylation analysis of fragile X-related epigenetic elements may provide a suitable newborn screening test for fragile X syndrome.
    Godler DE; Slater HR; Amor D; Loesch DZ
    Genet Med; 2010 Sep; 12(9):595. PubMed ID: 20838083
    [No Abstract]   [Full Text] [Related]  

  • 2. Fragile X-related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study.
    Inaba Y; Herlihy AS; Schwartz CE; Skinner C; Bui QM; Cobb J; Shi EZ; Francis D; Arvaj A; Amor DJ; Pope K; Wotton T; Cohen J; Hewitt JK; Hagerman RJ; Metcalfe SA; Hopper JL; Loesch DZ; Slater HR; Godler DE
    Genet Med; 2013 Apr; 15(4):290-8. PubMed ID: 23060046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epigenetics of fragile X syndrome.
    Warren ST
    Cell Stem Cell; 2007 Nov; 1(5):488-9. PubMed ID: 18938744
    [No Abstract]   [Full Text] [Related]  

  • 4. Testing for fragile X gene mutations throughout the life span.
    Hagerman RJ; Hagerman PJ
    JAMA; 2008 Nov; 300(20):2419-21. PubMed ID: 19033593
    [No Abstract]   [Full Text] [Related]  

  • 5. Prenatal diagnosis of fragile X syndrome complicated by full mutation retraction.
    Stark Z; Francis D; Gaffney L; Greenberg J; Hills L; Li X; Godler DE; Slater HR
    Am J Med Genet A; 2015 Oct; 167A(10):2485-7. PubMed ID: 25988754
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring for Epigenetic Modifications at the FMR1 Locus.
    Epsztejn-Litman S; Eiges R
    Methods Mol Biol; 2019; 1942():29-48. PubMed ID: 30900173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in prenatal screening and counselling for fragile X syndrome.
    Mak AS; Leung KY
    Hong Kong Med J; 2017 Apr; 23(2):108-9. PubMed ID: 28387201
    [No Abstract]   [Full Text] [Related]  

  • 8. Epigenetics of fragile X syndrome and fragile X-related disorders.
    Kraan CM; Godler DE; Amor DJ
    Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA Methylation at Birth Predicts Intellectual Functioning and Autism Features in Children with Fragile X Syndrome.
    Kraan CM; Baker EK; Arpone M; Bui M; Ling L; Gamage D; Bretherton L; Rogers C; Field MJ; Wotton TL; Francis D; Hunter MF; Cohen J; Amor DJ; Godler DE
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A faster strategy for prenatal diagnosis of fragile X syndrome.
    Schmitt S; Giraud M; Hary J; Rival JM; Bezieau S; Boisseau P
    Prenat Diagn; 2010 Dec; 30(12-13):1217-9. PubMed ID: 20842624
    [No Abstract]   [Full Text] [Related]  

  • 11. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis of Fragile X syndrome.
    Sofocleous C; Kolialexi A; Mavrou A
    Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn, carrier, and early childhood screening recommendations for fragile X.
    Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E
    Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome.
    Obstet Gynecol; 2010 Oct; 116(4):1008-1010. PubMed ID: 20859177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study for the neonatal screening of fragile X syndrome.
    Rifé M; Mallolas J; Badenas C; Tazón B; Miguélez MR; Pàmpols T; Sànchez A; Milà M
    Prenat Diagn; 2002 Jun; 22(6):459-62. PubMed ID: 12116303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of
    Kumari D; Usdin K
    Expert Rev Mol Diagn; 2020 Apr; 20(4):363-365. PubMed ID: 32067539
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic defects behind fragile X-related disorders more common: researchers find the incidence of one type of FMR1 allele double its previous estimate in males.
    Am J Med Genet A; 2013 Apr; 161A(4):x-xi. PubMed ID: 23520123
    [No Abstract]   [Full Text] [Related]  

  • 18. Current controversies in prenatal diagnosis 1: screening for fragile X syndrome.
    Yaron Y; Musci T; Cuckle H
    Prenat Diagn; 2013 Jan; 33(1):6-8. PubMed ID: 23079963
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiplex methylation specific PCR analysis of fragile X syndrome: experience in Songklanagarind Hospital.
    Charalsawadi C; Sripo T; Limprasert P
    J Med Assoc Thai; 2005 Aug; 88(8):1057-61. PubMed ID: 16404832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel polymorphism in the FMR1 gene: implications for clinical testing of fragile X syndrome.
    Thyagarajan B; Bower M; Berger M; Jones S; Dolan M; Wang X
    Arch Pathol Lab Med; 2008 Jan; 132(1):95-8. PubMed ID: 18181681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.